Recipient
Qualisure Diagnostics Inc.Department
National Research Council CanadaAmount
$200.0K
Province
ABType
C
Agreement Number
1034631
Purpose
Develop and Scale the firm's Molecular deCoder™ (MDR) Precision Clinical Diagnostics Platform into an open platform to support the firm's Proprietary Precision Oncology diagnostic tests in development and to empower third-party clinical diagnostics developers to use the Firm's platform to advance AI-driven Precision Oncology-based solutions for clinical guidance and decision-making.
Qualisure Diagnostics Inc. × National Research Council Canada
3 grants totalling $239.0K
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $111.3M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $10.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $10.0M | Industrial Research Assistance Program –... |